1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,040 | 0,046 | 23:00 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | LIFECARE ASA: Mandatory Notification of Trade by Primary Insider | 3 | Oslo Børs | ||
| Di | LIFECARE ASA: Lifecare successfully manufactures first functional implants in-house in Bergen | 4 | Oslo Børs | ||
| 15.09. | Lifecare ASA: Share capital increase registered | 2 | Oslo Børs | ||
| 31.08. | OCEAN GEOLOOP ASA: Captured AS enters into agreement to sell its shares in its subsidiary Ocean Tunicell AS to Lifecare ASA | 2 | Oslo Børs | ||
| 31.08. | Lifecare ASA acquires 80% of Ocean TuniCell securing established GMP manufacturing infrastructure in Bergen | 4 | Oslo Børs | ||
| 19.08. | LIFE: Lifecare ASA Q2 2026 results | 4 | Oslo Børs | ||
| 12.08. | Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST | 1 | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 02.07. | Lifecare ASA: LIFE: Update on production transfer and longevity programme | 2 | Oslo Børs | ||
| 26.06. | Lifecare ASA: LIFE: Operational update regarding Lifecare Germany GmbH (i.L) | 4 | Oslo Børs | ||
| 22.06. | Lifecare ASA: Share capital increase registered | 6 | Oslo Børs | ||
| 22.06. | Lifecare ASA: LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation | 3 | Oslo Børs | ||
| 12.06. | Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue | 6 | Oslo Børs | ||
| 12.06. | Lifecare ASA: Last day of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue | 3 | Oslo Børs | ||
| 10.06. | Lifecare ASA: Mandatory notification of trade | 2 | Oslo Børs | ||
| 10.06. | Lifecare ASA: Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response | 1 | Oslo Børs | ||
| 05.06. | Lifecare ASA: Last day of trading in Warrants Series 2 issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 03.06. | Lifecare ASA: Mandatory notification of trade | 1 | Oslo Børs | ||
| 01.06. | Lifecare ASA: Commencement of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 29.05. | Lifecare ASA: Exercise price for Warrants Series 2 issued in connection with the Rights Issue | - | Oslo Børs | ||
| 15.05. | LIFE: Lifecare ASA Q1 2026 results | 3 | Oslo Børs |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,066 | +6,82 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 37,780 | -0,15 % | Elutia Inc.: Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029 | Boston Scientific released the full $8 million holdback on schedule and with no claimsEscrow release is the third funding catalyst Elutia has delivered in 2026, following the August closings of its... ► Artikel lesen | |
| PAUL HARTMANN | 196,50 | 0,00 % | Januar bis Juni 2026: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - - Erfolgreiches 1. Halbjahr: Umsatzerlöse steigen auf 1.252,0 Mio. EUR, organisches Umsatzwachstum von 3,3 %; bereinigtes EBITDA liegt mit 151,7 Mio. EUR um 25,9 Mio. EUR über Vorjahreswert-... ► Artikel lesen | |
| SYSMEX | 10,120 | -3,53 % | Dividendenbekanntmachungen (29.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 77 BANK LTD JP3352000008 52 JPY 0,2906 EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1799 EUR ACOM CO LTD JP3108600002 11 JPY 0... ► Artikel lesen | |
| EMBECTA | 5,184 | +3,18 % | Dividendenbekanntmachungen (27.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDTECH AB SE0014781795 3,6 SEK 0,3243 EUR ALLIANCE WITAN PLC GB00B11V7W98 0,0733 GBP 0,0855 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
| ADDLIFE | 14,860 | -1,52 % | AddLife AB: AddLife acquires Unicam Sistemas Analíticos Lda | AddLife has acquired Unicam Sistemas Analíticos, a leading Portuguese distributor of advanced analytical laboratory equipment. The company will be included within AddLife's Business Area Labtech.Unicam... ► Artikel lesen | |
| ENOVIS | 16,000 | +1,27 % | UBS cuts Enovis stock price target on acquisition impact | ||
| PULMONX | 1,610 | -3,59 % | Pulmonx Corporation: Pulmonx Reports Second Quarter 2026 Financial Results | REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| SI-BONE | 15,800 | -1,86 % | SI-BONE, Inc.: SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx, Extending Its Compromised Bone Franchise Beyond the Pelvis | SANTA CLARA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised... ► Artikel lesen | |
| KOOTH | 2,120 | 0,00 % | Kooth PLC - Holding(s) in Company | ||
| PEIJIA MEDICAL | 0,500 | +1,21 % | Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth | SUZHOU, China, Aug. 24, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and... ► Artikel lesen | |
| BACTIGUARD | 1,215 | +0,41 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2026 | Solid performance driven by revenue growth
Second quarter 2026 (April - June)Total revenue amounted to SEK 57.1 (52.1) million, an increase of SEK 4.9 million corresponding to 9%.Net sales amounted... ► Artikel lesen | |
| SCIBASE | 1,215 | +0,41 % | Scibase Holding AB: SciBase announces outcome of rights issue of shares | SciBase Holding AB (publ) ("SciBase" or the "Company") today, on 1 October 2026, announces the outcome of the rights issue of shares of approximately SEK 57.5 million resolved by the Board of Directors... ► Artikel lesen | |
| PHC HOLDINGS | 9,200 | 0,00 % | Übernahmeangebot von Toho katapultiert PHC Holdings-Aktie auf fast Vierjahreshoch | ||
| FRESENIUS | 43,865 | -0,38 % | Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA | DJ Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA
DOW JONES--Die Fresenius-Tochter Kabi hat einen Warnschuss von der US-Gesundheitsbehörde FDA erhalten. In dem am Dienstag veröffentlichten... ► Artikel lesen |
LIFECARE ASA gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +50,74 % bei einem Aktienkurs von 0,041 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.